Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

INS-37217 Intranasal improves multiple perennial allergic rhinitis symptoms in phase II trial

Aug. 14, 2002

Novel CCR2 antagonists prepared by BMS researchers

Aug. 13, 2002

Sch-351591 as an effective oral therapy for asthma and COPD

Aug. 13, 2002

Tiotropium is better than salmeterol in improving lung function in COPD patients

Aug. 12, 2002

Novel prostaglandin D2 antagonists included in Merck Frosst patent

Aug. 7, 2002

Collaboration agreement announced for the development of emphysema treatment

Aug. 7, 2002

IND submitted for IL-4/13 Trap in asthma patients

Aug. 5, 2002

Discovery Labs and Aerogen collaborate on aerosol-delivered surfactants

Aug. 2, 2002

Novel tryptase inhibitors emerge from Boehringer Ingelheim

Aug. 1, 2002

Potential new treatment for cystic fibrosis designated an orphan drug

July 31, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.